Litcius/Paper detail

Actinium-225 targeted alpha particle therapy for prostate cancer

Anil P. Bidkar, Luann Zerefa, Surekha Yadav, Henry F. VanBrocklin, Robert R. Flavell

2024Theranostics67 citationsDOIOpen Access PDF

Abstract

Tb, providing viable alternatives for TAT.

Topics & Concepts

Prostate cancerAlpha particleMedicineAlpha (finance)CancerOncologyCancer researchInternal medicinePhysicsNuclear physicsNursingPatient satisfactionConstruct validityRadiopharmaceutical Chemistry and ApplicationsProstate Cancer Treatment and ResearchMedical Imaging Techniques and Applications
Actinium-225 targeted alpha particle therapy for prostate cancer | Litcius